Ewa Bielecka
Krakow, MA, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Anti-gingipain antibodies and ACE1 activity in rheumatoid arthritis: associations with disease activity and cardiovascular comorbidity in a cross-sectional study.
Journal: Rheumatology international
Published: June 01, 2026
Glycosaminoglycans activate peptidylarginine deiminase 4 by enhancing calcium affinity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 30, 2025
Kallikrein 14 activates the chemoattractant protein chemerin in human skin.
Journal: The Journal of biological chemistry
Published: October 14, 2025
Isoform-Selective PAD2/PAD4 Substrates with Unnatural Amino Acids Enable Cellular Peptidylarginine Deiminase Activity Profiling and Reveal Vimentin Citrullination Effects in Macrophages.
Journal: Biochemistry
Published: September 25, 2025
Novel Biomarker for Rheumatoid Arthritis: Serum Peptidylarginine Deiminase 4-Potentiating Activity in an Anti-Citrullinated Protein Antibody-Positive At-Risk Population.
Journal: Scandinavian journal of immunology
Published: May 19, 2025
Human tissue kallikrein 14 induces the expression of IL-6, IL-8, and CXCL1 in skin fibroblasts through protease-activated receptor 1 signaling.
Journal: The FEBS journal
Published: November 19, 2024
Corrigendum to "SARS-CoV-2 Mpro oligomerization as a potential target for therapy" [Int. J. Biol. Macromol. 267 (Part 1) (May 2024) 131392].
Journal: International journal of biological macromolecules
Published: July 18, 2024
SARS-CoV-2 Mpro oligomerization as a potential target for therapy.
Journal: International journal of biological macromolecules
Published: March 05, 2024
Identification of a new genetic variant (G231N, E232T, N235D) of peptidylarginine deiminase from P. gingivalis in advanced periodontitis.
Journal: Frontiers in immunology
Published: December 13, 2023
Last Updated: 09/26/2026